Dec 16, 2022 | Sheri Baker
Three years ago, when I attended the American Society of Hematology (ASH) Annual Meeting, the darling of the dance was Darzalex® (daratumumab). They combined Darzalex® with everything and with great results. The past couple of years CAR-T therapy took over as the most...
Dec 16, 2022 | Robin Tuohy
Heads up: this blog will not contain any specific abstract information, but rather to give you a bit of history and flavor of the daily schedules for leaders volunteering their time selflessly to bring you their patient perspectives. Please read their blogs for...
Dec 12, 2022 | John DeFlice
“The impossible exists only until we find a way to make it possible.” Mike Horn Emily Whitehead was five years old when she was diagnosed with acute lymphoblastic leukemia (ALL). After being treated with chemotherapy for two years, she experienced a failure of therapy...
Dec 1, 2022 | Linda Huguelet
I’m in my 12th year as a myeloma patient, and this is my 10th year to attend the American Society of Hematology (ASH) Conference. I was reminded of my first ASH recently when I placed a red origami bird, from the Takeda Oncology exhibit booth in 2013, on my Christmas...
